Engineered enzyme reduced AGE damage in human tissue samples
A proof-of-concept study reported that an engineered enzyme removed advanced glycation end products from human tissue samples in the lab, lowering the damage to levels similar to those of a much younger person.
Source: Engineered enzyme reduced AGE damage in human tissue samples (x.com). Summary written with AI from the source and reviewed by rules; read the original.
What the research shows
A proof-of-concept study reported that an engineered enzyme was able to remove advanced glycation end products (AGEs) from human tissue samples. According to the report, the damage measured in samples from a 75-year-old donor dropped to levels similar to those found in a 31-year-old person. The source does not give details such as the number of samples or how long the experiment lasted.
AGEs are substances that form when sugars react with proteins. They build up mainly in long-lived proteins such as collagen, which stays in tissues for years, so they are studied as one factor linked to tissue aging. Because this is a proof-of-concept study using tissue samples, it shows that the enzyme can work in this setting, but it does not show effects in living people, safety, or any health benefit. Research like this is usually an early step on a long path before any clinical use.
What it means
The finding suggests that AGEs built up in tissues may be removable with an engineered enzyme. It is still unknown whether this would work inside a living body, whether it would bring health benefits, or whether it would be safe over time.
How to read it with care
This result does not replace a medical consultation. Anyone considering a change in diet, supplements or treatment should talk to a doctor or another qualified health professional.